Study Identifies Most Accurate Noninvasive Method for Diagnosing MASH
A recent study compared the predictive performance of three imaging models in order to determine the most accurate noninvasive method for diagnosing MASH.
Read MoreAug 25, 2024
A recent study compared the predictive performance of three imaging models in order to determine the most accurate noninvasive method for diagnosing MASH.
Read MoreAug 24, 2024
High FIB-4 scores were linked to significantly greater healthcare resource utilization and costs among patients with MASH/NASH.
Read MoreAug 23, 2024
A recent clinical trial showed that probiotic supplementation in patients with early-stage NASH/MASH did not significantly improve liver or clinical parameters.
Read MoreAug 22, 2024
A unique set of cytokine and chemokine markers could serve as biomarkers to differentiate non-alcoholic steatohepatitis from non-alcoholic fatty liver disease.
Read MoreAug 21, 2024
Understanding patient experiences with MASH symptoms and their effect on day to-day life can enhance patient-clinician discussions and facilitate patient-centered treatment and disease management, according to a real-world,...
Read More